Institutional investors purchased a net $1.8 million shares of NVS during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 9.04% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ROBECO INVESTMENT MANAGEMENT, IN... Bought 2.3 Million shares of Novartis AG
TIAA-CREF INVESTMENT MANAGEMENT ... Bought 761.3 Thousand shares of Novartis AG
FIDELITY MANAGEMENT & RESEARCH C... Bought 683.2 Thousand shares of Novartis AG